Furthermore, miR-513c is markedly downregulated in hepatocellular carcinoma and glioblastoma (GBM) and overexpression of this miRNA prevented the proliferation of these cancer cells through targeting MET and Wnt/β-catenin signaling pathway, respectively [23, 25]. The gene discussed is MET; the disease is cancer.